Status:
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Lead Sponsor:
AstraZeneca
Conditions:
Diabetes
Eligibility:
All Genders
18-77 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alone
Detailed Description
All subjects will participate in a lead-in period, and qualifying subjects will continue into a short-term randomized treatment period. Subjects who complete the short-term period will be eligible to ...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Inadequate blood sugar control
- No current treatment with other medications to lower blood sugar
Exclusion
- Major heart, liver or kidney problems
- Pregnant or breast feeding
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
1306 Patients enrolled
Trial Details
Trial ID
NCT00327015
Start Date
May 1 2006
End Date
December 1 2008
Last Update
April 29 2015
Active Locations (211)
Enter a location and click search to find clinical trials sorted by distance.
1
East Bay Clinical Trial Center
Concord, California, United States, 94520
2
Encompass Clinical Research
Encinitas, California, United States, 92024
3
Community Clinical Trials
Orange, California, United States, 92868
4
Coastal Biomedical Research Inc
Santa Monica, California, United States, 90404